ALTASCIENCES CLINICAL KANSAS INC
OVERLAND PARK, KANSAS 662121758
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $4.93M | 11 |
| 541712 | $146K | 4 |
Contract Awards
6 awards found
INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 11, 2026. N01DA-23-8935
INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. POP: 5/2/2025 - 11/1/2026. N01DA-23-8935
INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. SEPTEMBER 20, 2017 THROUGH SEPTEMBER 19, 2022
RATIFICATION OF AN UNAUTHORIZED COMMITMENT FOR THE DOSE FINDING STUDY OF KRATOM ALKALOIDS PILOT
PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893
Business Details
- UEI
- WZ5RGEMMQ3W9
- CAGE Code
- 6PS73
- Address
- 10103 METCALF AVE
OVERLAND PARK, KS 662121758 - Congressional District
- KS-03
- Phone
- 9136961601
Parent Company
ALTASCIENCES CLINICAL KANSAS INC.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov